PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain.\', \'Department of Internal Medicine, Hospital Universitario de Fuenlabrada, Madrid, Spain.\', \'Department of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain.\', \'Department of Hematology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.\', \'Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.\', \'Department of Internal Medicine, Hospital Cantoblanco, Madrid, Spain.\', \'Department of Intensive Care, Hospital Universitario La Paz, Madrid, Spain.\', \'Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain.\', \'Cardiovascular Division, Brigham and Women\'s Hospital, Harvard Medical School, Boston, Massachusetts, USA.\', \'Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, Connecticut, USA.\', \'Cardiovascular Research Foundation, New York, New York, USA.\', \'Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain.\', \'Universidad de Alcalá (IRYCIS), Madrid, Spain.\', \'CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.\', \'Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Spain.\', \'Universidad Católica de Murcia, Universidad Autònoma de Barcelona, CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/jth.15400
?:doi
?:hasPublicationType
?:journal
  • Journal of thrombosis and haemostasis : JTH
is ?:pmid of
?:pmid
?:pmid
  • 34018658
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all